Nicole Lemerond - 10 Aug 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric Adams, attorney-in-fact for Ms. Nicole Lemerond
Issuer symbol
INM
Transactions as of
10 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 20:14:31 UTC
Previous filing
10 Aug 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +14,000 $0.000000 14,000 10 Aug 2022 Common shares 14,000 $0.3900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on Aug 10, 2022 and will vest monthly, in arrears, as follows: (i) 390 stock options will vest on the 10th day of each month for 35 months, and (ii) 350 stock options will vest on Aug 10, 2025 (the three year anniversary of Grant date).